Literature DB >> 8732747

Cystic fibrosis therapy--where we are and how we got there.

D C Gruenert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8732747      PMCID： PMC1303523     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  12 in total

1.  Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease.

Authors:  P A DI SANT'AGNESE; R C DARLING; G A PERERA; E SHEA
Journal:  Pediatrics       Date:  1953-11       Impact factor: 7.124

2.  Cyclic adenosine monophosphate-dependent kinase in cystic fibrosis tracheal epithelium.

Authors:  R Barthelson; J Widdicombe
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

3.  Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses.

Authors:  Y Yang; Q Li; H C Ertl; J M Wilson
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

4.  Chloride impermeability in cystic fibrosis.

Authors:  P M Quinton
Journal:  Nature       Date:  1983-02-03       Impact factor: 49.962

5.  Inflammatory cytokines in cystic fibrosis lungs.

Authors:  T L Bonfield; J R Panuska; M W Konstan; K A Hilliard; J B Hilliard; H Ghnaim; M Berger
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

6.  Cystic fibrosis decreases the apical membrane chloride permeability of monolayers cultured from cells of tracheal epithelium.

Authors:  J H Widdicombe; M J Welsh; W E Finkbeiner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

7.  A cystic fibrosis mutation associated with mild lung disease.

Authors:  K H Gan; H J Veeze; A M van den Ouweland; D J Halley; H Scheffer; A van der Hout; S E Overbeek; J C de Jongste; W Bakker; H G Heijerman
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245

8.  Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis.

Authors:  M Knowles; J Gatzy; R Boucher
Journal:  N Engl J Med       Date:  1981-12-17       Impact factor: 91.245

Review 9.  Cystic fibrosis in adults. From researcher to practitioner.

Authors:  G P Marelich; C E Cross
Journal:  West J Med       Date:  1996-04

10.  Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection.

Authors:  M F Tosi; H Zakem-Cloud; C A Demko; J R Schreiber; R C Stern; M W Konstan; M Berger
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.